Business Description

Titan Biotech Ltd. can be described as a holding company. It is involved in the production of peptone, extract, as well as chemicals. Products include pharmaceuticals and nutraceuticals as well as food additives, biotechnology, fermentation, cosmetic ingredients, and veterinary and animal feed ingredients.

It manufactures biological products like peptone and malt extract, yeast extract, liver extraction, and others. The company also trades in handicapped goods. The company was established in Delhi, India on February 18, 1992.

Key Financials

Revenue (US$ Mn)

• Titan Biotech Ltd.’s annual revenue for 2021 was US$ 21 Mn, a 7.88% increase from 2020
• The annual revenue generated by Titan Biotech Ltd. in 2020 was US$ 19 Mn
• At a 20.88% increase, Titan Biotech Ltd.’s annual revenue of US$ 11 Mn was indexed in 2019
• Titan Biotech Ltd. generated total revenue of US$ 9 Mn in 2018

Operating Income (US$ Mn)

• US$ 385 Mn was the operating income generated by Titan Biotech Ltd. in 2021
• Titan Biotech Ltd.’s operating income for 2020 was US$ 444 Mn, a 279.49% increase from 2019
• From 2018’s operating incomes, Titan Biotech Ltd. registered a 58.11% increase in 2019, amounting to US$ 117 Mn
• An operating income of US$ 74 Mn was generated in 2018 by Titan Biotech Ltd.

Net Income (US$ Mn)

• Titan Biotech Ltd.’s net income for 2021 was US$ 253 Mn, a -16.5% decrease from 2020
• The net income generated by Titan Biotech Ltd. in 2020 was US$ 303 Mn
• At a 102.86% increase, Titan Biotech Ltd.’s net income of US$ 71 Mn was indexed in 2019
• Titan Biotech Ltd. generated a net income of US$ 35 Mn in 2018

Operating Margin %

• Titan Biotech Ltd.’s operating margin for 2021 was 25%, a -19.23% decrease from 2020
• The operating margin generated by Titan Biotech Ltd. in 2020 was 31%
• At a 28.95% increase, Titan Biotech Ltd.’s operating margin of 15% was indexed in 2019
• Titan Biotech Ltd. generated an operating margin of 11% in 2018

Gross Margin %

• Titan Biotech Ltd.’s gross margin for 2021 was 51%, an 8.28% increase from 2020
• The gross margin generated by Titan Biotech Ltd. in 2020 was 47%
• At a 5.82% increase, Titan Biotech Ltd.’s gross margin of 40% was indexed in 2019
• Titan Biotech Ltd. generated a gross margin of 38% in 2018

SWOT Analysis

Strengths

Get this premium content

The Premium data is Locked

Buy Now to Unlock Premium Data

Request Sample Data